找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phospho; W. R. Bartle,V. Braun,N. E. Winslade

[復(fù)制鏈接]
樓主: NO610
11#
發(fā)表于 2025-3-23 10:03:40 | 只看該作者
Biopharmacological Regulation of Protein Phosphorylation,we indicate the inhibition or activation mechanisms of each compound and examine selectivity for each kinase, then describe the representative experiments of biological applications of these compounds. The possible clinical application of these compounds warrant attention.
12#
發(fā)表于 2025-3-23 16:30:00 | 只看該作者
0177-8757 addition, certain specialized tissues use cholesterol as the basic substrate for the synthesis of more complicated sterols such as bile acids and the steroid hormones. Like most lipids cholesterol has a very low solubility in water. Therefore, in order for these molecules to be transported be- twee
13#
發(fā)表于 2025-3-23 18:36:21 | 只看該作者
14#
發(fā)表于 2025-3-24 00:34:37 | 只看該作者
Pharmacokinetic Drug Interactions,s review discusses the various pharmacokinetic mechanisms involved in these changes and discusses several drug and patient-specific factors that aid in assessing the clinical significance of these interactions.
15#
發(fā)表于 2025-3-24 02:52:56 | 只看該作者
Regulation of Plasma Low Density Lipoprotein Levels: New Strategies for Drug Design,or-dependent LDL-cholesterol degradation accounts for the majority of total LDL-cholesterol degradation in all species studied. Third, in quantitative terms, receptor-dependent LDL-cholesterol degradation is restricted to the liver and, to a lesser extent, the small intestine. It is also clear that
16#
發(fā)表于 2025-3-24 06:47:58 | 只看該作者
17#
發(fā)表于 2025-3-24 13:07:51 | 只看該作者
Conference proceedings 1988seen. Since it has been demonstrated that reducing the steady-state plasma LDL-cholesterol concentration produces a proportional decrease in the risk of developing atherosclerosis 2), a major effort is now underway to develop safe and effective lipid lowering agents. In the past, these efforts have
18#
發(fā)表于 2025-3-24 16:35:29 | 只看該作者
0177-8757 the risk of developing atherosclerosis 2), a major effort is now underway to develop safe and effective lipid lowering agents. In the past, these efforts have 978-3-642-72904-1978-3-642-72902-7Series ISSN 0177-8757
19#
發(fā)表于 2025-3-24 22:27:22 | 只看該作者
20#
發(fā)表于 2025-3-25 01:01:03 | 只看該作者
s of this social reality. Finally, the authors examine new challenges emerging from recent paradigm shifts within forensic genetics, moving away from the construction of evidence as presented in court to the production of intelligence guiding criminal investigations.978-981-15-2429-5
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 04:11
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
仪征市| 探索| 当雄县| 潞城市| 河间市| 平罗县| 东乡| 英山县| 康定县| 咸宁市| 苏尼特左旗| 黑龙江省| 皋兰县| 灵山县| 沽源县| 元谋县| 遂昌县| 天津市| 宝丰县| 库车县| 樟树市| 二连浩特市| 芜湖市| 西林县| 赤峰市| 霍山县| 澄城县| 如东县| 崇阳县| 江津市| 福泉市| 门源| 怀宁县| 陆良县| 太谷县| 杭州市| 上饶县| 南澳县| 贵南县| 山西省| 临夏县|